Dr. Esther Choo, ER Physician at OHSU in Portland, speaks with Dr. Jack West about being an outsider growing up, as well as her path into medicine & interest in emergency medicine, where care intersects with broad social issues. (21:33)
Drs. William Dale & Jack West, both from City of Hope Comprehensive Cancer Center, reflect on the challenges of having patients & fellow health care professionals welcome integration of supportive care alongside aggressive anti-cancer treatments. (20:24)
Dr. William Dale from City of Hope Comprehensive Cancer Center discusses with host Jack West how he became interested in supportive care & geriatric oncology, as well as societal biases in treating older patients. (25:45)
Dr. Chadi Nabhan & host Jack West consider the challenge of pruning career activities after struggling to define priorities & say no to opportunities; Dr. Nabhan reviews the value of real world evidence in evaluating cancer treatments. (19:39)
Dr. Chadi Nabhan speaks with host Jack West & reviews his circuitous course from medical training in Syria to lymphoma specialist & rising administrator in Chicago to his decision to pursue an MBA, leading him into a world of the business of health care. (23:18)
Lecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School debriefs with host Dr. Jack West about key ASCO 2019 findings in EGFR mutation-positive NSCLC & her campaign for the IASLC Board of Directors. (23:57)
Lecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School speaks with Dr. Jack West about the trajectory of her early career and focusing on both the science of medicine & practical concerns while speaking out on social media. (27:08)
Dr. Sumanta (Monty) Pal of City of Hope Comprehensive Cancer Center describes his precocious entry into medicine, the tremendous opportunities it has afforded him in ASCO leadership and GU oncology, his commitment to mentorship, & his work/life balance. (32:11)
Drs. Heather Wakelee and Jack West review how she entered & became a leader in thoracic oncology, her prioritization of mentorship, & her efforts to continue the strong momentum of the International Association of the Study of Lung Cancer (IASLC). (30:27)
Dr. West speaks with Dr. Ross Camidge about the experience of contributing to the NCCN guidelines, developing the ATOMIC network as a novel platform for lung cancer research, & the increasing importance of online patient molecularly defined groups. (10:25)